231 related articles for article (PubMed ID: 25084685)
21. Protein-protein interaction of the human poly(ADP-ribosyl)transferase depends on the functional state of the enzyme.
Griesenbeck J; Oei SL; Mayer-Kuckuk P; Ziegler M; Buchlow G; Schweiger M
Biochemistry; 1997 Jun; 36(24):7297-304. PubMed ID: 9200678
[TBL] [Abstract][Full Text] [Related]
22. Identification of evolutionary and kinetic drivers of NAD-dependent signaling.
Bockwoldt M; Houry D; Niere M; Gossmann TI; Reinartz I; Schug A; Ziegler M; Heiland I
Proc Natl Acad Sci U S A; 2019 Aug; 116(32):15957-15966. PubMed ID: 31341085
[TBL] [Abstract][Full Text] [Related]
23. DNA damage in Nijmegen Breakage Syndrome cells leads to PARP hyperactivation and increased oxidative stress.
Krenzlin H; Demuth I; Salewsky B; Wessendorf P; Weidele K; Bürkle A; Digweed M
PLoS Genet; 2012; 8(3):e1002557. PubMed ID: 22396666
[TBL] [Abstract][Full Text] [Related]
24. Natural selection and functional diversification of the epidermal growth factor receptor EGFR family in vertebrates.
Liu Y; He W; Long J; Pang F; Xian L; Chen M; Wu Y; Hu Y
Genomics; 2013 Jun; 101(6):318-25. PubMed ID: 23499669
[TBL] [Abstract][Full Text] [Related]
25. Regulation of poly(ADP-ribose) polymerase-1-dependent gene expression through promoter-directed recruitment of a nuclear NAD+ synthase.
Zhang T; Berrocal JG; Yao J; DuMond ME; Krishnakumar R; Ruhl DD; Ryu KW; Gamble MJ; Kraus WL
J Biol Chem; 2012 Apr; 287(15):12405-16. PubMed ID: 22334709
[TBL] [Abstract][Full Text] [Related]
26. In silico characterization of the family of PARP-like poly(ADP-ribosyl)transferases (pARTs).
Otto H; Reche PA; Bazan F; Dittmar K; Haag F; Koch-Nolte F
BMC Genomics; 2005 Oct; 6():139. PubMed ID: 16202152
[TBL] [Abstract][Full Text] [Related]
27. Non-canonical roles of NAMPT and PARP in inflammation.
Martínez-Morcillo FJ; Cantón-Sandoval J; Martínez-Menchón T; Corbalán-Vélez R; Mesa-Del-Castillo P; Pérez-Oliva AB; García-Moreno D; Mulero V
Dev Comp Immunol; 2021 Feb; 115():103881. PubMed ID: 33038343
[TBL] [Abstract][Full Text] [Related]
28. Poly(ADP-ribose). The most elaborate metabolite of NAD+.
Bürkle A
FEBS J; 2005 Sep; 272(18):4576-89. PubMed ID: 16156780
[TBL] [Abstract][Full Text] [Related]
29. Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked?
Zhang J
Bioessays; 2003 Aug; 25(8):808-14. PubMed ID: 12879452
[TBL] [Abstract][Full Text] [Related]
30. Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling.
Ruf A; de Murcia G; Schulz GE
Biochemistry; 1998 Mar; 37(11):3893-900. PubMed ID: 9521710
[TBL] [Abstract][Full Text] [Related]
31. NAD+ as a metabolic link between DNA damage and cell death.
Ying W; Alano CC; Garnier P; Swanson RA
J Neurosci Res; 2005 Jan 1-15; 79(1-2):216-23. PubMed ID: 15562437
[TBL] [Abstract][Full Text] [Related]
32. Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation.
Gibson BA; Zhang Y; Jiang H; Hussey KM; Shrimp JH; Lin H; Schwede F; Yu Y; Kraus WL
Science; 2016 Jul; 353(6294):45-50. PubMed ID: 27256882
[TBL] [Abstract][Full Text] [Related]
33. [Biological activity of poly(ADP-ribose)polymerase-1].
Kiliańska ZM; Zołnierczyk J; Wesierska-Gadek J
Postepy Hig Med Dosw (Online); 2010 Jul; 64():344-63. PubMed ID: 20679690
[TBL] [Abstract][Full Text] [Related]
34. Differential action of natural selection on the N and C-terminal domains of 2'-5' oligoadenylate synthetases and the potential nuclease function of the C-terminal domain.
Rogozin IB; Aravind L; Koonin EV
J Mol Biol; 2003 Mar; 326(5):1449-61. PubMed ID: 12595257
[TBL] [Abstract][Full Text] [Related]
35. Identification of Protein Substrates of Specific PARP Enzymes Using Analog-Sensitive PARP Mutants and a "Clickable" NAD
Gibson BA; Kraus WL
Methods Mol Biol; 2017; 1608():111-135. PubMed ID: 28695507
[TBL] [Abstract][Full Text] [Related]
36. Cellular Compartmentation and the Redox/Nonredox Functions of NAD
Kulkarni CA; Brookes PS
Antioxid Redox Signal; 2019 Sep; 31(9):623-642. PubMed ID: 30784294
[No Abstract] [Full Text] [Related]
37. PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.
van Beek L; McClay É; Patel S; Schimpl M; Spagnolo L; Maia de Oliveira T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066057
[TBL] [Abstract][Full Text] [Related]
38. Poly(ADP-ribose) polymerase: molecular biological aspects.
de Murcia G; Ménissier-de Murcia J; Schreiber V
Bioessays; 1991 Sep; 13(9):455-62. PubMed ID: 1796908
[TBL] [Abstract][Full Text] [Related]
39. Using Clickable NAD
Zhang L; Lin H
Methods Mol Biol; 2017; 1608():95-109. PubMed ID: 28695506
[TBL] [Abstract][Full Text] [Related]
40. Induction of ROS formation, poly(ADP-ribose) polymerase-1 activation, and cell death by PCB126 and PCB153 in human T47D and MDA-MB-231 breast cancer cells.
Lin CH; Lin PH
Chem Biol Interact; 2006 Aug; 162(2):181-94. PubMed ID: 16884709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
